植入炎市場 - 全球產業規模、佔有率、趨勢、機會、預測：按類型、最終用戶、地區和競爭對手分類，2021-2031年

全球植入炎市場預計將從 2025 年的 110.2443 億美元大幅成長至 2031 年的 176.7986 億美元，複合年成長率為 8.19%。

植體周圍植入是一種病理性炎症，其特徵是人工植牙周圍軟組織發炎和支持骨骼進行性喪失。推動這一市場發展的主要因素是全球人工植牙數量的不斷成長，而人口老化和無牙顎患病率上升是主要促進因素。隨著植入數量的累積增加，植體周圍植入生物併發症的發生率自然也隨之上升，對診斷和治療方案產生了持續的需求。例如，根據美國植入學會 (AAID) 的數據，到 2025 年，美國將有約 300 萬人接受人工植牙，這意味著有大量面臨疾病風險的患者族群。

市場促進因素

人工植牙手術數量的不斷成長是全球植體周圍植入市場的主要驅動力。這是因為植入數量的增加與生物併發症發生率的上升直接相關，導致需要治療性介入的患者群體擴大。主要產業參與者的強勁表現也印證了這一趨勢，顯示植入治療將持續成長。同時，再生醫學和雷射治療技術的進步為臨床醫生提供了更可預測、更有效率的生物膜清除和組織保存方案，從而推動了市場擴張。電解清潔系統和先進雷射治療方法等創新技術有效克服了機械清創的局限性，並提高了治療的接受度。為制定統一的、循證的植入疾病管理指南而進行的合作，進一步凸顯了該行業致力於標準化這些先進治療方法的決心。

市場挑戰

阻礙市場成長的一大挑戰是植體周圍植入再生治療臨床結果的不確定性。缺乏普遍認可的標準化方案，使得牙科專業人員對保守治療的長期成功率存在很大的不確定性。這種信心的缺失常常導致臨床醫生選擇拔除植入，而不是投資或推薦成本高昂且療效不確定的保守治療，限制了先進市場解決方案的普及。這種臨床上的不確定性，加上植入周圍炎治療保險報銷的不一致性，進一步強化了拔牙作為更可預測且更經濟的選擇的傾向。儘管2025年的臨床數據顯示，約有22%的植入患者將患有植體周圍植入，但這種趨勢限制了診斷和再生產品的收入潛力。

市場趨勢

全球植入炎市場正經歷一場變革，其驅動力主要來自人工智慧 (AI) 和數位影像技術的融合，尤其是在早期檢測方面的應用。這正將臨床重點從被動治療轉向預測性監測。雲端原生平台和人工智慧驅動的診斷技術能夠以前所未有的精準度識別早期骨吸收和軟組織異常，從而實現標準化治療，並在嚴重併發症發生前及時介入。互聯診斷生態系統的快速發展也為此提供了有力支撐，例如，登士柏西諾德 (Dentsply Sirona) 的數位平台 DS Core 擁有超過 37,000 名不重複訪客。同時，牙科領域的併購策略整合正在建立強大的垂直整合網路，從而簡化複雜植入治療的流程。這些整合統一了植入系統、數位化工作流程和耗材，提高了營運效率，擴大了市場進入，並促進了治療效果的一致性。因此，市場分散化程度降低，標準化植入解決方案的採用也得到鞏固。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球植體周圍植入市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 按類型（非手術、手術）
  • 依最終使用者（牙科診所、醫院）分類
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美植入周圍炎市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲植入周圍炎市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區植體周圍植入市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲植入周圍炎市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲植入周圍炎市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球植體植入炎市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Straumann Group
• Dentsply Sirona Inc.
• Zimmer Biomet Holdings, Inc.
• Nobel Biocare Services AG
• Institut Straumann AG
• BioHorizons IPH, Inc.
• Keystone Dental, Inc.
• Thommen Medical AG
• Neoss Limited
• MegaGen Implant Co., Ltd.

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Peri-implantitis Market is projected to grow substantially from USD 11,024.43 Million in 2025 to USD 17,679.86 Million by 2031, at an 8.19% Compound Annual Growth Rate. Peri-implantitis is a pathological inflammatory condition characterized by soft tissue inflammation and the progressive loss of supporting bone around a dental implant. The market's primary driver is the increasing global volume of dental implant procedures, fueled by an aging population and rising rates of edentulism. As the cumulative number of placed implants increases, the incidence of biological complications like peri-implantitis naturally rises, creating a sustained demand for diagnostic and therapeutic solutions. For example, approximately three million individuals in the United States had dental implants in 2025, according to the American Academy of Implant Dentistry, representing a significant patient pool susceptible to this disease.

Market Driver

The expanding volume of dental implant procedures serves as the main catalyst for the Global Peri-implantitis Market, as the rising count of placed implants directly correlates with a higher incidence of biological complications, thereby increasing the patient pool requiring therapeutic intervention. This trend is underscored by robust financial results from key industry players, signaling continued growth in implant therapy. Concurrently, technological advancements in regenerative and laser therapies are propelling market expansion by providing clinicians with more predictable and efficient protocols for biofilm decontamination and tissue preservation. Innovations such as electrolytic cleaning systems and advanced laser modalities are effectively overcoming limitations of mechanical debridement, thus encouraging higher treatment acceptance. The industry's commitment to standardizing these advanced interventions is further demonstrated by collaborative efforts to establish unified, evidence-based guidelines for managing peri-implant diseases.

Market Challenge

A significant challenge impeding market growth is the unpredictability of clinical outcomes associated with current regenerative treatments for peri-implantitis. The absence of a universally standardized protocol creates considerable uncertainty for dental professionals regarding the long-term success of preservation therapies. This lack of confidence often leads clinicians to opt for implant removal rather than investing in or recommending costly and uncertain preservation procedures, thereby suppressing the adoption of advanced market solutions. This clinical uncertainty, compounded by inconsistent insurance reimbursement for peri-implantitis management, frequently biases decision-making toward explantation as a more predictable and financially prudent alternative. This preference limits the revenue potential for diagnostic and regenerative products, even though clinical data from 2025 indicated peri-implantitis affected roughly 22% of patients with dental implants.

Market Trends

The Global Peri-implantitis Market is undergoing transformation driven by key trends, primarily the integration of Artificial Intelligence and digital imaging for early detection, which shifts clinical focus from reactive treatment to predictive monitoring. Cloud-native platforms and AI-driven diagnostics enable unprecedented precision in identifying initial bone loss and soft tissue anomalies, standardizing care and facilitating timely interventions before significant complications arise. This is supported by the rapid uptake of connected diagnostic ecosystems, as evidenced by Dentsply Sirona's DS Core digital platform exceeding 37,000 unique users. Simultaneously, strategic consolidation through mergers and acquisitions in dental care is establishing robust, vertically integrated networks that streamline the delivery of complex implant therapies. These consolidations aggregate implant systems, digital workflows, and consumables, enhancing operational efficiency, broadening market access, and fostering consistent procedural outcomes, thereby mitigating market fragmentation and solidifying the adoption of standardized implant solutions.

Key Market Players

• Straumann Group
• Dentsply Sirona Inc.
• Zimmer Biomet Holdings, Inc.
• Nobel Biocare Services AG
• Institut Straumann AG
• BioHorizons IPH, Inc.
• Keystone Dental, Inc.
• Thommen Medical AG
• Neoss Limited
• MegaGen Implant Co., Ltd.

Report Scope

In this report, the Global Peri-implantitis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Peri-implantitis Market, By Type

• Non-Surgical
• Surgical

Peri-implantitis Market, By End-User

• Dental Clinics
• Hospitals

Peri-implantitis Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Peri-implantitis Market.

Available Customizations:

Global Peri-implantitis Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Peri-implantitis Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Non-Surgical, Surgical)
  • 5.2.2. By End-User (Dental Clinics, Hospitals)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Peri-implantitis Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By End-User
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Peri-implantitis Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By End-User
  • 6.3.2. Canada Peri-implantitis Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By End-User
  • 6.3.3. Mexico Peri-implantitis Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By End-User

7. Europe Peri-implantitis Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By End-User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Peri-implantitis Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By End-User
  • 7.3.2. France Peri-implantitis Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By End-User
  • 7.3.3. United Kingdom Peri-implantitis Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By End-User
  • 7.3.4. Italy Peri-implantitis Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By End-User
  • 7.3.5. Spain Peri-implantitis Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By End-User

8. Asia Pacific Peri-implantitis Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By End-User
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Peri-implantitis Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By End-User
  • 8.3.2. India Peri-implantitis Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By End-User
  • 8.3.3. Japan Peri-implantitis Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By End-User
  • 8.3.4. South Korea Peri-implantitis Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By End-User
  • 8.3.5. Australia Peri-implantitis Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By End-User

9. Middle East & Africa Peri-implantitis Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By End-User
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Peri-implantitis Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By End-User
  • 9.3.2. UAE Peri-implantitis Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By End-User
  • 9.3.3. South Africa Peri-implantitis Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By End-User

10. South America Peri-implantitis Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By End-User
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Peri-implantitis Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By End-User
  • 10.3.2. Colombia Peri-implantitis Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By End-User
  • 10.3.3. Argentina Peri-implantitis Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By End-User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Peri-implantitis Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Straumann Group
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Dentsply Sirona Inc.
• 15.3. Zimmer Biomet Holdings, Inc.
• 15.4. Nobel Biocare Services AG
• 15.5. Institut Straumann AG
• 15.6. BioHorizons IPH, Inc.
• 15.7. Keystone Dental, Inc.
• 15.8. Thommen Medical AG
• 15.9. Neoss Limited
• 15.10. MegaGen Implant Co., Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer